Georgia Hanley-Vargas

Georgia Hanley-Vargas

Auto-generated profile, based on publicly available information

Georgia Hanley-Vargas

Hospital Clínica Bíblica

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
CRCarolina Rojas-Chinchilla
Carolina Rojas-Chinchilla
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
DQDiego Quesada-Loría
Diego Quesada-Loría
JGJonathan Garcia
Jonathan Garcia
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
Laboratory-acquired infections (LAIs) pose significant risks to laboratory personnel, public health, and the environment, despite the implementation of biosafety measures. This study provides a comprehensive analysis of global LAIs reported from 1974 to 2024, identifying trends, causes, and pathogen distributions to address gaps in biosafety knowledge. A systematic literature review was conducted using databases such as PubMed, Cochrane, Google Scholar, and the American Biological Safety Association (ABSA). A total of 234 studies meeting strict inclusion criteria were analyzed. Bacterial pathogens accounted for 58.6% of reported incidents, followed by viruses at 36.1%. Procedural errors and accidents were the predominant causes of LAIs, with Brucella spp. being the most frequently reported pathogen, primarily in China. Temporal trends indicated a decline in incidents coinciding with the implementation of international biosafety regulations. However, disparities in incident reporting and compliance remain evident across countries. This study underscores the urgent need for a global regulatory framework, mandatory biosafety audits, a centralized incident database, and standardized training for high-containment laboratory personnel. Enhancing global collaboration, transparency in research, and adherence to ethical standards will further reduce LAI risks and strengthen public health security worldwide.

2 July 2024 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
GHGeorgia Hanley
Georgia Hanley
SJSilvia Vargas Jiménez
Silvia Vargas Jiménez
EVEleaneth Baltodano Viales
Eleaneth Baltodano Viales
JUJuan Miguel Zúñiga Umaña
Juan Miguel Zúñiga Umaña
JVJosé Vega-Baudrit
José Vega-Baudrit
Luis Castillo-HenríquezLuis Castillo-Henríquez
Luis Castillo-Henríquez
ObjectiveThis work aims to present a Quality-by-Design (QbD) step-by-step methodology to formulate anti-ulcer and gastro-protective oral suspensions.MethodsSucralfate was used as a drug model. The Quality Target Product Profile was established early during preformulation. Viscosity, resuspendability, pH, and density were assessed through the screening of several suspension platforms based on different prototype compositions. A compatibility study between the active pharmaceutical ingredient and the excipients was performed by thermal analysis and infrared spectroscopy. An Ishikawa fishbone diagram and Failure Mode and Effect Analysis were employed to identify the Critical Material Attributes (CMAs), Critical Process Parameters (CPPs), and Critical Quality Attributes (CQAs). CMAs' and CPPs' impact on identified CQAs was further assessed through a 22 full factorial experimental design at normal conditions after manufacture and one month at super-accelerated stress conditions. Results: The lead prototype exhibited no physicochemical incompatibilities. The risk assessment tools revealed that the concentration of the wetting agent and the total concentration of thickening agents represented critical factors for the quality profile of the preparation in terms of viscosity. The optimized formulation comprising 1.125 w/v% total concentration of Natrosol 250 HX and Avicel RC 591 exhibited an enhanced performance according to the established profile.ConclusionsThe analytical and physicochemical tests showed the robustness and compliance of the final preparation with the quality profile. The proposed step-by-step methodology based on QbD, Design of Experiments, and Quality Risk Management presented in our research holds practical implications for local industries and formulation scientists involved in the development of oral suspensions.

25 March 2026 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
SSSofía Suárez-Sánchez
Sofía Suárez-Sánchez
LALuis Andrés Aguilar-Castro
Luis Andrés Aguilar-Castro
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Background/Objectives: AI-based tools for chest radiograph interpretation are increasingly used as decision-support systems, yet their performance must be validated in local clinical environments before deployment. This study evaluated the diagnostic performance of qXR (Qure.ai, v3.2) for detecting pulmonary nodules, cardiomegaly, and pleural effusion in adult patients at Hospital Clínica Bíblica, San José, Costa Rica. Methods: Three radiologists independently interpreted 225 chest radiographs, providing the reference standard. qXR outputs were compared against radiologist assessments for each finding. The sensitivity, specificity, Cohen’s kappa, and area under the ROC curve (AUC) were calculated. Due to the convenience-stratified sampling design, predictive values were not used for clinical interpretation. Results: For pulmonary nodules, qXR achieved a sensitivity of 0.71, specificity of 0.90, Cohen’s kappa of 0.51, and AUC of 0.80. For pleural effusion, sensitivity and specificity were both 0.86, with a kappa of 0.63 and AUC of 0.86. Cardiomegaly showed the lowest agreement, with a sensitivity of 0.64, specificity of 0.91, kappa of 0.57, and AUC of 0.77. Conclusions: qXR demonstrated moderate diagnostic agreement with radiologist assessments for pulmonary nodules and pleural effusion, and lower agreement for cardiomegaly under local imaging conditions. These results reflect technical concordance between the AI system and individual radiologists and do not constitute evidence of clinical utility or real-world impact. Context-specific validation is essential prior to integrating AI tools into routine radiological workflows.

7 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
SSSofía Suárez-Sánchez
Sofía Suárez-Sánchez
LALuis Andrés Aguilar-Castro
Luis Andrés Aguilar-Castro
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Background/Objectives: Artificial intelligence (AI) tools for chest X-ray interpretation have gained relevance as support systems in diagnostic workflows, particularly in settings with high demand or limited specialist availability. This study evaluated the diagnostic performance of the qXR software (Qure.ai) for detecting high-risk pulmonary nodules, cardiomegaly, and pleural effusion in adult patients at Hospital Clínica Bíblica in San José, Costa Rica. Methods: Three radiologists independently interpreted 225 chest radiographs, serving as the reference standard. qXR results were compared against this standard for each finding. Sensitivity, specificity, Cohen’s kappa, and area under the curve (AUC) were calculated. Predictive values were not used for interpretation due to the artificial prevalence of the sample. Results: qXR showed higher agreement with radiologist assessments for pulmonary nodules and pleural effusion, achieving moderate to substantial concordance. Performance for cardiomegaly was more variable, with lower agreement across evaluators. Overall diagnostic accuracy was acceptable, although the magnitude differed by condition. Conclusions: These findings underscore the importance of validating AI diagnostic tools within local clinical environments and heterogeneous imaging conditions. qXR demonstrated potential as a complementary aid for detecting pulmonary nodules and pleural effusion, while its performance for cardiomegaly should be interpreted with caution. The study does not provide evidence of real-world clinical impact.

31 March 2026 in Journal of Patient Experience
Verified
Journal Article
Open access
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
DQDiego Quesada-Loría
Diego Quesada-Loría
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
AMAbigail Fallas Mora
Abigail Fallas Mora
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
This study evaluated patient experience in a private hospital in Costa Rica using the Picker Patient Experience Questionnaire-33 (PPE-33). A digital survey administered via Qualtrics ® targeted patients treated in emergency, surgical, or inpatient units between November 2024 and February 2025. A total of 567 valid responses were analyzed, exceeding the required sample size. The mean PPE-33 score indicated a satisfaction rate of 67.6%. The lowest-rated dimension was Patient Rights (27.9%), with few patients reporting being informed about their rights. In comparison, higher scores were observed for patient information (90.4%) and for confidentiality, privacy, pain management, and care (82.0%). Statistically significant differences were observed only by occupational status ( p =  .0122), with no variation by sex, age, educational level, or marital status. The emergency department consistently showed the lowest ratings across several dimensions. Overall, the findings highlight strengths and persistent gaps in patient-centered care and support the use of digital surveys as a feasible tool for monitoring patient experience and guiding quality improvement efforts in similar private hospital settings.